Deal facts
- Buyer
- Sandoz Inc.
- Target
- Coherus Ophthalmology LLC
- Deal value
- USD 187,800,000
- Announced
- 19 January 2024
- Status
- Completed
- Sector
- Healthcare
- Country
- United States
- Consideration
- cash
Sources
Weekly digest
Join Exit Mode Insider
Ten deal briefs a week, founder commentary, and the patterns worth paying attention to.
Join Exit Mode Insider, £12/moDeal timeline
1 update- CompletedClosed
Sandoz Inc. completes acquisition of Coherus Ophthalmology LLC
Introductory Note As previously announced, on January 19, 2024, Coherus BioSciences, Inc., a Delaware corporation (the “Company”), entered into a Purchase and Sale Agreement (as amended, restated, supplemented or otherwise modified from time to time, the “Purchase Agreement”) by and between the Company and Sandoz Inc., a Delaware corporation (“Purchaser”). On March 1, 2024, the Company completed
Source
Explore
Browse adjacent archives
Jump from this deal into the sector, buyer, deal type, and year views that carry the strongest contextual signal.
Similar deals
Similar deals
Other Healthcare M&A activity tracked by Exit Mode.
GA SNF ABBEVILLE GA LLC and GA SNF EASTMAN GA LLC to acquire Selectis Health, Inc.
GA SNF ABBEVILLE GA LLC and GA SNF EASTMAN GA LLC and Selectis Health, Inc. entered the Exit Mode archive.
- Buyer
- GA SNF ABBEVILLE GA LLC and GA SNF EASTMAN GA LLC
- Target
- Selectis Health, Inc.
- Deal value
- USD 15,700,000
- Deal type
- asset sale
MeiraGTx Holdings plc to acquire Janssen Pharmaceuticals, Inc.
MeiraGTx Holdings plc and Janssen Pharmaceuticals, Inc. entered the Exit Mode archive.
- Buyer
- MeiraGTx Holdings plc
- Target
- Janssen Pharmaceuticals, Inc.
- Deal value
- USD 25,000,000
- Deal type
- asset sale
Supernus Pharmaceuticals, Inc. to acquire Navitor Pharmaceuticals, Inc.
Supernus Pharmaceuticals, Inc. and Navitor Pharmaceuticals, Inc. entered the Exit Mode archive.
- Buyer
- Supernus Pharmaceuticals, Inc.
- Target
- Navitor Pharmaceuticals, Inc.
- Deal value
- USD 350,000,000
- Deal type
- asset sale
SCYNEXIS, Inc. to acquire Poxel SA
SCYNEXIS, Inc. and Poxel SA entered the Exit Mode archive.
- Buyer
- SCYNEXIS, Inc.
- Target
- Poxel SA
- Deal value
- USD 8,000,000
- Deal type
- asset sale
Vireo Health of Rocky Mountain, LLC to acquire Medicine Man Technologies, Inc. d/b/a Schwazze
Vireo Health of Rocky Mountain, LLC and Medicine Man Technologies, Inc. d/b/a Schwazze entered the Exit Mode archive.
- Buyer
- Vireo Health of Rocky Mountain, LLC
- Target
- Medicine Man Technologies, Inc. d/b/a Schwazze
- Deal value
- USD 111,000,000
- Deal type
- asset sale
Buyer history
Sandoz Inc.
See every published Exit Mode archive entry where this buyer appears.
View buyer profileMethodology
How this page is built
Layer 1 facts come from source documents, Layer 2 turns those facts into a readable narrative, and Layer 3 only appears where the editorial team flags a founder-relevant deal.
Back to the archive